{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:31:41Z","timestamp":1773808301631,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.seizure.2020.03.016","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T02:07:55Z","timestamp":1586484475000},"page":"96-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Treatment of generalized convulsive status epilepticus: An international survey in the East Mediterranean Countries"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6195-0307","authenticated-orcid":false,"given":"Sahar","family":"Farhat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6487-8259","authenticated-orcid":false,"given":"Wassim","family":"Nasreddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taoufik","family":"Alsaadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan A","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9047-1185","authenticated-orcid":false,"given":"Ahmad","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2020.03.016_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy currents"},{"key":"10.1016\/j.seizure.2020.03.016_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocritical care"},{"key":"10.1016\/j.seizure.2020.03.016_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4065\/76.1.39","article-title":"Treatment of nonfebrile status epilepticus in Rochester, Minn, from 1965 through 1984","author":"Cascino","year":"2001","journal-title":"Mayo Clinic Proceedings Elsevier"},{"key":"10.1016\/j.seizure.2020.03.016_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1684\/epd.2007.0069","article-title":"Treatment adherence and outcomes in the management of convulsive status epilepticus in the emergency room","volume":"9","author":"Muayqil","year":"2007","journal-title":"Epileptic disorders"},{"key":"10.1016\/j.seizure.2020.03.016_bib0025","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1528-1167.2010.02688.x","article-title":"Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice","volume":"51","author":"Aranda","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2020.03.016_bib0030","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.seizure.2020.03.016_bib0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12028-012-9790-1","article-title":"Treatment of status epilepticus: an international survey of experts","volume":"18","author":"Riviello","year":"2013","journal-title":"Neurocritical care"},{"key":"10.1016\/j.seizure.2020.03.016_bib0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus","volume":"339","author":"Treiman","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.seizure.2020.03.016_bib0045","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.1983.03330350028021","article-title":"Double-blind study of lorazepam and diazepam in status epilepticus","volume":"249","author":"Derivan","year":"1983","journal-title":"Jama"},{"key":"10.1016\/j.seizure.2020.03.016_bib0050","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2014.2625","article-title":"Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial","volume":"311","author":"Chamberlain","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.seizure.2020.03.016_bib0055","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.seizure.2020.03.016_bib0060","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF00427897","article-title":"Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam","volume":"86","author":"Ellinwood","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.seizure.2020.03.016_bib0065","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.seizure.2020.03.016_bib0070","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.seizure.2020.03.016_bib0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00415-011-6227-2","article-title":"Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study","volume":"259","author":"Misra","year":"2012","journal-title":"Journal of neurology"},{"key":"10.1016\/j.seizure.2020.03.016_bib0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2020.03.016_bib0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with iv valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.seizure.2020.03.016_bib0090","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2020.03.016_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Yasiry","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2020.03.016_bib0100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00002018-200022060-00004","article-title":"Fosphenytoin and phenytoin in patients with status epilepticus","volume":"22","author":"DeToledo","year":"2000","journal-title":"Drug safety"},{"key":"10.1016\/j.seizure.2020.03.016_bib0105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40263-014-0167-1","article-title":"Efficacy and safety of intravenous valproate for status epilepticus: a systematic review","volume":"28","author":"Trinka","year":"2014","journal-title":"CNS drugs"},{"key":"10.1016\/j.seizure.2020.03.016_bib0110","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/ane.12928","article-title":"department, T.s.g.o.s.i.t.e. and adults, s.e.i. Why we prefer levetiracetam over phenytoin for treatment of status epilepticus","volume":"137","author":"Zaccara","year":"2018","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.seizure.2020.03.016_bib0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/epi.12288","article-title":"The established status epilepticus trial 2013","volume":"54","author":"Bleck","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2020.03.016_bib0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Archives of neurology"},{"key":"10.1016\/j.seizure.2020.03.016_bib0125","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/jnnp.74.8.1095","article-title":"The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists","volume":"74","author":"Holtkamp","year":"2003","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.seizure.2020.03.016_bib0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fneur.2013.00192","article-title":"Clinical pharmacology and pharmacokinetics of levetiracetam","volume":"4","author":"Wright","year":"2013","journal-title":"Frontiers in neurology"},{"key":"10.1016\/j.seizure.2020.03.016_bib0135","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s40262-015-0276-0","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of lacosamide","volume":"54","author":"Cawello","year":"2015","journal-title":"Clinical pharmacokinetics"},{"key":"10.1016\/j.seizure.2020.03.016_bib0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenetics and genomics"},{"key":"10.1016\/j.seizure.2020.03.016_bib0145","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1528-1157.1989.tb05818.x","article-title":"Pharmacokinetics and clinical use of parenteral phenytoin, phenobarbital, and paraldehyde","volume":"30","author":"Ramsay","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2020.03.016_bib0150","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2020.03.016_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bja.2018.12.025","article-title":"Propofol infusion syndrome: a structured literature review and analysis of published case reports","author":"Hemphill","year":"2019","journal-title":"British journal of anaesthesia"},{"key":"10.1016\/j.seizure.2020.03.016_bib0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2015.05.010","article-title":"Ketamine for the treatment of refractory status epilepticus","volume":"30","author":"Fang","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2020.03.016_bib0165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","article-title":"Predictors of outcome in refractory status epilepticus","volume":"70","author":"Hocker","year":"2013","journal-title":"JAMA neurology"},{"key":"10.1016\/j.seizure.2020.03.016_bib0170","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2014.11.007","article-title":"Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus","volume":"22","author":"Kang","year":"2015","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1016\/j.seizure.2020.03.016_bib0175","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"European journal of neurology"},{"key":"10.1016\/j.seizure.2020.03.016_bib0180","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/epi.14706","article-title":"Duration of therapeutic coma and outcome of refractory status epilepticus","volume":"60","author":"Muhlhofer","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2020.03.016_bib0185","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1528-1157.1998.tb01177.x","article-title":"Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus","volume":"39","author":"DeLorenzo","year":"1998","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131120301035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131120301035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:55:29Z","timestamp":1761011729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131120301035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":37,"alternative-id":["S1059131120301035"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2020.03.016","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of generalized convulsive status epilepticus: An international survey in the East Mediterranean Countries","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2020.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}